Brainstorm Cell Therapeutics (GHD) Q4 2024 Earnings Report
DE:GHD Q4 2024 EPS Results
- Actual EPS
- -EUR 0.40
- Consensus EPS
- -EUR 0.87
- Beat/Miss
- Beat by +EUR 0.47
- One Year Ago EPS
- -EUR 0.67
DE:GHD Q4 2024 Revenue Results
- Actual Revenue
- EUR 0
- Expected Revenue
- EUR 0
- Beat/Miss
- Met expectations
- YoY Revenue Growth
- ―
Earnings Announcement Details
- Quarter
- Q4 2024
- Date
- 03/31/2025
- Time
- Before Open
- Conference Call
- Monday, March 31, 2025
DE:GHD Upcoming Earnings
Brainstorm Cell Therapeutics's next earnings date is estimated for November 16, 2026, based on past reporting schedules.
Q4 2024 Earnings Call Audio
DE:GHD Q4 2024 Earnings Call
0:00 / 0:00
Q4 2024 Earnings Slide Deck
No slide deck is available for this earnings event.
Q4 2024 Earnings Call Summary
No earnings call summary is available for this earnings event.
DE:GHD Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Nov 16, 2026 | 2026 (Q3) | -0.16- | -0.17 | ― | ― |
| Aug 14, 2026 | 2026 (Q2) | ―-0.31 | -0.3 | -2.94% (-0.01) | |
| May 15, 2026 | 2026 (Q1) | ―-0.17 | -0.4 | 57.78% (+0.23) | |
| Mar 31, 2026 | 2025 (Q4) | -0.25-0.17 | -0.4 | 57.78% (+0.23) | |
| Nov 14, 2025 | 2025 (Q3) | -0.33-0.17 | -0.46 | 62.75% (+0.29) | |
| Aug 14, 2025 | 2025 (Q2) | -0.33-0.30 | 0.54 | -156.67% (-0.84) | |
| May 16, 2025 | 2025 (Q1) | ―-0.40 | -0.67 | 40.00% (+0.27) | |
| Mar 31, 2025 | 2024 (Q4) | -0.87-0.40 | -0.67 | 40.00% (+0.27) | |
| Nov 14, 2024 | 2024 (Q3) | -0.51-0.46 | -0.4 | -13.33% (-0.05) | |
| Aug 14, 2024 | 2024 (Q2) | -0.470.54 | -1.75 | 130.77% (+2.28) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
